Dopaminergic system genes in childhood aggression: Possible role for DRD2

References

• Achenbach TM, Rescorla LA. 2001. Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: University of Vermont, Research Centre for Children, Youth and Families.
   Google Scholar
• Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. 2002. Risperidone Disruptive Behavior Study Group. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159(8):1337–1346.
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. 4th. text revision. Washingtonc, DC: American Psychiatric Association.
   Google Scholar
• Archer J. 2004. Sex differences in aggression in real-world settings: a meta-analytic review. Rev Gen Psychol 8(4):291–322.
   Google Scholar
• Arsenio WF. 2004. The stability of young children's physical aggression: relations with child care, gender, and aggression subtypes. Monogr Soc Res Child Dev 69(4):130–144.
   Google Scholar
• Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HHM. 1995. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157–1165.
   PubMed Web of Science ®Google Scholar
• Bakermans-Kranenburg MJ, van Ijzendoorn MH. 2006. Geneenvironment interaction of the dopamine D4 receptor (DRD4) and observed maternal insensitivity predicting externalizing behavior in preschoolers. Dev Psychobiol 48(5):406–409.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
   PubMed Web of Science ®Google Scholar
• Bartels M, Hudziak JJ, Van Den Ord EJ, Van Beijsterveldt CE, Rietveld MJ, Boomsma DI. 2003. Co-occurrence of aggressive behaviour and rule-breaking behaviour at age 12: multi-rater analysis. Behav Genet 33:607–621.
   PubMed Web of Science ®Google Scholar
• Bhana N, Foster RH, Olney R, Plosker GL. 2001. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 61:111–161.
   PubMed Web of Science ®Google Scholar
• Brizer DA. 1988. Psychopharmacolgy and the management of violent patients. Psychiatr Clin North Am 11:551–568.
   PubMedGoogle Scholar
• Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT. 2001. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62(4):239–248.
   Google Scholar
• Buckley PF. 1999. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry 60:52–60.
   PubMed Web of Science ®Google Scholar
• Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, Anderson L. 1984. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41(7):650–656.
   Google Scholar
• Caron C, Rutter M. 1991. Comorbidity in child psychopathology: concepts, issues, and research strategies. J Child Psychol Psychiatry 32:1063–1080.
   PubMed Web of Science ®Google Scholar
• Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, . 2002. Role of genotype in the cycle of violence in maltreated children. Science 297(5582):851–854.
   PubMed Web of Science ®Google Scholar
• Chalsani L, Kant R, Chengappa R. 2001. Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood onset schizophrenia. Can J Psychiatry 46:965–968.
   Google Scholar
• Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. 1996. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 98:91–101.
   PubMed Web of Science ®Google Scholar
• Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, . 2003. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry 8:393–396.
   PubMed Web of Science ®Google Scholar
• Chen TJH, Blum K, Mathews K, Fisher L, Schnautz N, Braverman ER, . 2005. Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of “super normal controls” in psychiatric genetic research of complex behavioral disorders. Med Hypotheses 65:703–707.
   PubMed Web of Science ®Google Scholar
• Chengappa KN, Vasile J, Levine J, Ulrich R, Baker R, Gopalani A, Schooler N. 2002. Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophr Res 53(1–2):1–6.
   Google Scholar
• Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, . 2000. Comparison of the role of dopamine, serotonin, and noradrenalin genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57:178–196.
   PubMed Web of Science ®Google Scholar
• Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT, DBH and DRD5 to affected children. Mol Psychiatry 4:192–196.
   PubMed Web of Science ®Google Scholar
• Deater-Deckard K, Plomin R. 1999. An adoption study of the etiology of teacher and parent reports of externalizing behaviour problems in middle childhood. Child Dev 70:144–154.
   PubMed Web of Science ®Google Scholar
• Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV. 2003. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205–216.
   PubMed Web of Science ®Google Scholar
• Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P. 2004. The 3'region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67:75–85.
   Google Scholar
• Eley TC, Lichtenstein P, Moffitt TE. 2003. A longitudinal behavioural genetic analysis of the etiology of aggressive and nonagressive antisocial behaviour. Dev Psychopathol 15:383–402.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle AE, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeats of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052–1057.
   PubMed Web of Science ®Google Scholar
• Ferrari PF, Van Erp AM, Torantzky W, Miczek KA. 2003. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 17:371–378.
   PubMed Web of Science ®Google Scholar
• Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon ERN, Blumer JL. 2000. A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 39:509–516.
   PubMed Web of Science ®Google Scholar
• Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK. 2006. Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder. J Am Acad Child Adolesc Psychiatry 45(7):792–800.
   PubMed Web of Science ®Google Scholar
• Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK. 2007. A 26-week open-label study of quetiapine in children with conduct disorder. J Child Adolesc Psychopharmacol 17(1):1–9.
   Google Scholar
• Findling RL, Kauffman R, Sallee FR, Salazar DE, Sahasrabudhe V, Kollia G, . 2009. An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. J Child Adolesc Psychopharmacol 19(4):431–439.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured Clinical Interview for DSM IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute.
   Google Scholar
• Fresan A, Camarena B, Apiquian R, Aguilar A, Urraca N, Nicolini H. 2007. Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior. Neuropsychobiology 55(3–4):171–175.
   Google Scholar
• Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152–156.
   PubMedGoogle Scholar
• Garmendia L, Sánchez JR., Azpiroz A, Brain PF, Simón VM. 1992. Clozapine: strong antiaggressive effects with minimal motor impairment. Physiol Behav 51:51–54.
   Google Scholar
• Gauderman WJ, Morrison JM. 2006. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies [http://hydra.usc.edu/gxe].
   Google Scholar
• Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter. Mol Psychiatry 2:311–313.
   PubMed Web of Science ®Google Scholar
• Giros B, El Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG. 1992. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383–390.
   PubMed Web of Science ®Google Scholar
• Gorman EB, Klorman R, Thatcher JE, Borgstedt AD. 2006. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:808–816.
   PubMed Web of Science ®Google Scholar
• Greenwood TA, Kelsoe JR. 2003. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511–520.
   PubMedGoogle Scholar
• Guo G, Roettger ME, Shih JC. 2007. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet 121(1):125–136.
   Google Scholar
• Ito H, Nara H, Inoue-Murayama M, Shimada MK, Koshimura A, Ueda Y, . 2004. Allele frequency distribution of the canine dopamine receptor D4 gene exon III and I in 23 breeds. J Vet Med Sci 66(7):815–820.
   Google Scholar
• Jovanovic V, Guan HC, Van Tol HH. 1999. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics 9:561–568.
   PubMedGoogle Scholar
• Käll L, Storey JD, Noble WS. 2009. QVALITY: non-parametric estimation of q-values and posterior error probabilities. Bioinformatics 25(7):964–966.
   Google Scholar
• Kim JW, Park CS, Hwang JW, Shin MS, Hong KE, Cho SC, Kim BN. 2006. Clinical and genetic characteristics of Korean male alcoholics with and without attention deficit hyperactivity disorder. Alcohol Alcohol 41(4):407–411.
   Google Scholar
• Kim YR, Kim JH, Kim SJ, Lee D, Min SK. 2008. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population. Eur Neuropsychopharmacol 18(11):820–825.
   Google Scholar
• Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig IW, Moffitt TE. 2006. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 11(10): 903–913.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Nurnberger JI. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
   PubMed Web of Science ®Google Scholar
• LaHoste GJ, Swanson JM, Wiqal SB, Glabe C, Wiqal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121–124.
   PubMed Web of Science ®Google Scholar
• Lichter J, Barr C, Kennedy J, Van Tol H, Kidd K, Livak K. 1993. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 2:767–773.
   PubMed Web of Science ®Google Scholar
• Lonergan E, Luxenberg J, Colford J. 2001. Haloperiodal for agitation in dementia (Cochrane Review). Cochrane Database Syst Rev 4:CD002852.
   Google Scholar
• Maxwell E. 1992. The Family Interview for Genetic Studies: Manual. Clinical Neurogenetics Branch, Intramural Research Program. Washington, DC: National Institute of Mental Health [http://zork.wustl.edu/nimh/figs/figs_train.pdf].
   Google Scholar
• Miczek KA, Fish EW, de Bold JF, de Almeida RMM. 2002. Social and neural determinants of Aggressive behavior: Pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid systems. Psychopharmacology 163:434–458.
   PubMed Web of Science ®Google Scholar
• Miles DR, Carey G. 1997. Genetics and environmental architecture of human aggression. J Pers Soc Psychol 72:207–217.
   PubMed Web of Science ®Google Scholar
• Miller GM, Madras BK. 2002. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes effect reporter gene expression. Mol Psychiatry 7:44–55.
   PubMed Web of Science ®Google Scholar
• Min KA, Palmatier MA, Kidd KK. 1999. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46:151–160.
   Google Scholar
• Moffitt TE, Caspi A, Harrington H, Milne BJ. 2002. Males on the life-course-persistent and adolescence-limited antisocial pathways: Follow-upat age 26 years. Dev Psychopathol 14(1): 179–207.
   Google Scholar
• Mungas D, Weiler P, Franzi C, Henry R. 1989. Assessment of disruptive behavior associated with dementia: the Disruptive Behavior Rating Scales. J Ger Psychiatry Neurol 2(4):196–202.
   Google Scholar
• Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23: 540–545.
   PubMed Web of Science ®Google Scholar
• Nottelman ED, Jensen PS. 1995. Comorbidity of disorders in children and adolescents: Developmental perspectives. Ollendic, Prinz RJ. Advances in clinical child psychology. 17. New York: Plenum. 109–155.
   Google Scholar
• Noble EP. 1998. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16:33–45.
   PubMed Web of Science ®Google Scholar
• Paashius-Lew YR, Heddle JA. 1998. Spontaneous mutation during fetal development and post-natal growth. Mutagenesis 13(6):613–617.
   Google Scholar
• Pohjalainen J, Rinne JO, Nagren K, Lehikoinen P, Anttile K, Syvalahti EKG, Hietala J. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256–260.
   PubMed Web of Science ®Google Scholar
• Pritchard AL, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P, Lendon CL. 2009. Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 24(9):1020–1025.
   Google Scholar
• Purper-Ouakil D, Wohl M, Mouren MC, Verpillat P, Ades J, Gorwood P. 2005. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 15:53–59.
   PubMed Web of Science ®Google Scholar
• Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M. 2006. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry 163(3): 402–410.
   Google Scholar
• Rhee SH, Waldman ID. 2002. Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull 128(3):490–529.
   Google Scholar
• Rocca P, Marchiaro L, Cocuzza E, Bogetto F. 2002. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 63(3):241–244.
   Google Scholar
• Rodriguiz RM, Chu R, Caron MG, Wetsel WC. 2004. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 148:185–198.
   Google Scholar
• Sharp SI, McQuillin A, Gurling HM. 2009. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57(7–8):590–600.
   Google Scholar
• Sheese BE, Voelker PM, Rothbart MK, Posner MI. 2007. Parenting quality interacts with genetic variation in dopamine receptor D4 to influence temperament in early childhood. Dev Psychopathol 19(4):1039–1046.
   Google Scholar
• Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A; Risperidone Conduct Study Group. 2002. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41(9):1026–1036.
   Google Scholar
• Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. 1997. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69(2–3): 71–77.
   Google Scholar
• Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, . 2000. Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21–25.
   PubMed Web of Science ®Google Scholar
• Sweet RA, Nimgaonkar VL, Kamboh MI, Lopez OL, Zhang F, DeKosky ST. 1998. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch Neurol 55(10):1335–1340.
   Google Scholar
• Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, . 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human straitum associated with the A1 allele. Pharmacogenetics 7:479–484.
   PubMedGoogle Scholar
• Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, . 2010. A common polymorphism in the Cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology 35(6):1315–1324.
   Google Scholar
• Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ. 2001. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet 105:745–748.
   PubMedGoogle Scholar
• Van Beijsterveldt CE, Bartels M, Hudziak JJ, Boomsma DL. 2003. Cause of stability of aggression from early childhood to adolescence: a longitudinal analysis in Dutch twins. Behav Genet 33:591–605.
   PubMed Web of Science ®Google Scholar
• Van Bellinghen M, De Troch C. 2001. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 11(1): 5–13.
   Google Scholar
• Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HH. 2005. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem 280(19):19350–19357.
   Google Scholar
• Van den Oord EJ, Verhulst FC, Boomsma DI. 1996. A genetic study of maternal and paternal ratings of problem behaviors in 3-year-old twins. J Abnorm Psychol 105:349–357.
   PubMed Web of Science ®Google Scholar
• Vandenbergh DJ, Persico AM, Hawkins AL, Griffin DA, Li X, Jabs EW, Uhl GR. 1992. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104–1106.
   PubMed Web of Science ®Google Scholar
• van den Berg SW, Dollé ME, Imholz S, van der A DL, van ‘t Slot R, Wijmenga C, . 2009. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study. Int J Obes (London) 33:1143–1152.
   PubMed Web of Science ®Google Scholar
• Vaughn MG, Delisi M, Beaver KM, Wright JP. 2009. DAT1 and 5HTT are associated with pathological criminal behavior in a nationally representative sample of youth. Criminal Justice and Beh. 36:1113–1124.
   Web of Science ®Google Scholar
• Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, . 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767–1776.
   PubMed Web of Science ®Google Scholar
• Wechsler D. 1991. Manual for the Wechsler Intelligence Scale for Children. 3rd. San Antonio, TX: The Psychological Corporation.
   Google Scholar
• Wigginton JE, Abecasis GR. 2005. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21:3445–3447.
   PubMed Web of Science ®Google Scholar
• Xing Q, Qian X, Li H, Wong S, Wu S, Feng G, . 2006. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 14:1–7.
   Google Scholar
• Yodofsky SC, Silver JM, Schneider SE. 1987. Pharmacologic treatment of aggression. Psychiatr Ann 17:397.
   Google Scholar